1. miR-326 overexpression inhibits colorectal cancer cell growth and proteasome activity by targeting PNO1: unveiling a novel therapeutic intervention strategy
   Yi Fang et al, 2024, Scientific Reports CrossRef
2. PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway
   Long Fang et al, 2023, Scientific Reports CrossRef
3. Partner of NOB1 Homolog Transcriptionally Activated by E2F Transcription Factor 1 Promotes the Malignant Progression and Inhibits Ferroptosis of Pancreatic Cancer
   Qin Yang et al, 2023, Chinese Journal of Physiology CrossRef
4. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway
   Liu-jing Cao et al, 2024, Chinese Journal of Integrative Medicine CrossRef
5. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma
   Sanjit K. Roy et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
6. Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization
   Yilong Lin et al, 2024, Discover Oncology CrossRef
7. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
   Sanjit K. Roy et al, 2023, Journal of Cellular and Molecular Medicine CrossRef
8. Ribosome Biogenesis and Cancer: Insights into NOB1 and PNO1 Mechanisms
   Muthu Ragunath et al, 2024, Current Pharmaceutical Design CrossRef
9. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
   Fernanda Villarruel-Melquiades et al, 2023, World Journal of Gastroenterology CrossRef
10. Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration
    Yinhui Qin et al, 2024, Heliyon CrossRef